Annual SGA
$1.06 M
-$567.70 K-34.83%
September 1, 2024
Summary
- As of February 7, 2025, DRUG annual SGA is $1.06 million, with the most recent change of -$567.70 thousand (-34.83%) on September 1, 2024.
- During the last 3 years, DRUG annual SGA has fallen by -$749.30 thousand (-41.36%).
- DRUG annual SGA is now -46.80% below its all-time high of $2.00 million, reached on September 30, 2022.
Performance
DRUG SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$257.20 K
+$22.90 K+9.77%
September 1, 2024
Summary
- As of February 7, 2025, DRUG quarterly SGA is $257.20 thousand, with the most recent change of +$22.90 thousand (+9.77%) on September 1, 2024.
- Over the past year, DRUG quarterly SGA has dropped by -$37.50 thousand (-12.72%).
- DRUG quarterly SGA is now -64.39% below its all-time high of $722.30 thousand, reached on June 30, 2021.
Performance
DRUG Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$100.01 M
-$2.22 M-2.27%
September 1, 2024
Summary
- As of February 7, 2025, DRUG TTM SGA is -$100.01 million, with the most recent change of -$2.22 million (-2.27%) on September 1, 2024.
- Over the past year, DRUG TTM SGA has dropped by -$101.34 million (-7589.35%).
- DRUG TTM SGA is now -23841.90% below its all-time high of -$417.70 thousand.
Performance
DRUG TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
DRUG Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -34.8% | -12.7% | -7589.4% |
| 3 y3 years | -41.4% | -12.7% | -7589.4% |
| 5 y5 years | +1146.8% | -12.7% | -7589.4% |
DRUG Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -46.8% | at low | -63.0% | +9.8% | -290.7% | at low |
| 5 y | 5-year | -46.8% | +1146.8% | -64.4% | >+9999.0% | <-9999.0% | at low |
| alltime | all time | -46.8% | +1146.8% | -64.4% | >+9999.0% | <-9999.0% | at low |
Bright Minds Biosciences Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | $1.06 M(-34.8%) | $257.20 K(+9.8%) | $1.06 M(-7.4%) |
| Jun 2024 | - | $234.30 K(-13.1%) | $1.14 M(-4.1%) |
| Mar 2024 | - | $269.60 K(-8.5%) | $1.19 M(-10.9%) |
| Dec 2023 | - | $294.70 K(-13.9%) | $1.34 M(-18.0%) |
| Sep 2023 | $1.63 M(-18.4%) | $342.10 K(+21.0%) | $1.63 M(+0.7%) |
| Jun 2023 | - | $282.70 K(-32.0%) | $1.62 M(-10.5%) |
| Mar 2023 | - | $415.80 K(-29.2%) | $1.81 M(-4.7%) |
| Dec 2022 | - | $587.30 K(+78.0%) | $1.89 M(-5.4%) |
| Sep 2022 | $2.00 M | $330.00 K(-30.1%) | $2.00 M(-11.5%) |
| Jun 2022 | - | $472.10 K(-6.6%) | $2.26 M(-10.0%) |
| Mar 2022 | - | $505.40 K(-27.3%) | $2.51 M(+6.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | - | $695.30 K(+17.5%) | $2.36 M(+29.2%) |
| Sep 2021 | $1.81 M(+2026.3%) | - | - |
| Sep 2021 | - | $591.50 K(-18.1%) | $1.83 M(+39.7%) |
| Jun 2021 | - | $722.30 K(+104.4%) | $1.31 M(+118.1%) |
| Mar 2021 | - | $353.40 K(+118.7%) | $600.20 K(+143.1%) |
| Dec 2020 | - | $161.60 K(+125.4%) | $246.90 K(+189.1%) |
| Sep 2020 | $85.20 K | - | - |
| Sep 2020 | - | $71.70 K(+431.1%) | $85.40 K(+523.4%) |
| Jun 2020 | - | $13.50 K(>+9900.0%) | $13.70 K(+6750.0%) |
| Mar 2020 | - | $100.00(0.0%) | $200.00(+100.0%) |
| Dec 2019 | - | $100.00 | $100.00 |
FAQ
- What is Bright Minds Biosciences annual SGA?
- What is the all time high annual SGA for Bright Minds Biosciences?
- What is Bright Minds Biosciences annual SGA year-on-year change?
- What is Bright Minds Biosciences quarterly SGA?
- What is the all time high quarterly SGA for Bright Minds Biosciences?
- What is Bright Minds Biosciences quarterly SGA year-on-year change?
- What is Bright Minds Biosciences TTM SGA?
- What is the all time high TTM SGA for Bright Minds Biosciences?
- What is Bright Minds Biosciences TTM SGA year-on-year change?
What is Bright Minds Biosciences annual SGA?
The current annual SGA of DRUG is $1.06 M
What is the all time high annual SGA for Bright Minds Biosciences?
Bright Minds Biosciences all-time high annual SGA is $2.00 M
What is Bright Minds Biosciences annual SGA year-on-year change?
Over the past year, DRUG annual SGA has changed by -$567.70 K (-34.83%)
What is Bright Minds Biosciences quarterly SGA?
The current quarterly SGA of DRUG is $257.20 K
What is the all time high quarterly SGA for Bright Minds Biosciences?
Bright Minds Biosciences all-time high quarterly SGA is $722.30 K
What is Bright Minds Biosciences quarterly SGA year-on-year change?
Over the past year, DRUG quarterly SGA has changed by -$37.50 K (-12.72%)
What is Bright Minds Biosciences TTM SGA?
The current TTM SGA of DRUG is -$100.01 M
What is the all time high TTM SGA for Bright Minds Biosciences?
Bright Minds Biosciences all-time high TTM SGA is -$417.70 K
What is Bright Minds Biosciences TTM SGA year-on-year change?
Over the past year, DRUG TTM SGA has changed by -$101.34 M (-7589.35%)